A Prognostic Model for Multiple Myeloma Based on Lipid Metabolism Genes

sFigure 1 Removal of batch effects and external validation of the modelsFigure 2 Correlation of risk stratification with clinical events and Immune InfiltrationsFigure 3 Integration of model and clinical featuresTable s1 List of Lipid Metabolism Genes Table s2 GO Enrichment Results of Upregulated Genes in High Risk Groups Table s3 GO Enrichment Results of Upregulated Genes in Low Risk Groups Table s4 Differential Genes between High and Low Risk GroupsTable s5 Grouping of 985 patients under StepCox [backward]+RSF and StepCox [both]+RSF modelsTable s6 Univariate Cox regression analysis of lipid metabolism genes